Cardiac gene therapy stands at the forefront of revolutionary advancements in cardiovascular medicine, presenting a transformative approach to address a spectrum of heart-related challenges. This cutting-edge therapeutic method involves the precise introduction of specific genes into the cardiac system, aiming to rectify genetic anomalies, optimize myocardial performance, and impede the progression of various cardiac conditions. Through innovative gene delivery systems, researchers are delving into the possibilities of targeting conditions like arrhythmias and ischemic heart disease, paving the way for tailored interventions that go beyond traditional treatments. The dynamic landscape of cardiac gene therapy underscores a new era in cardiac care, offering a glimpse into the potential for highly individualized and impactful interventions that could redefine the future of cardiovascular health. As the field continues to evolve, the prospect of reshaping the landscape of cardiac medicine through gene-based therapies emerges as an exciting avenue of exploration and progress.
Title : Chronic angina and the health economics of cardiovascular risk reduction in macro- and microvascular coronary disease
Uwe Peter Tigor, Auxilius Pharma, United States
Title : Vericiguat Inhibits the Progress of Cardiac Hypertrophy and Prevents Hypertrophy Induced Heart Failure by Multiple Mechanisms
Guo Wei He, Tianjin University, China
Title : Not So Idiopathic After All: Genotype, Phenotype and IL-1 Blockade Response Converge in Recurrent Pericarditis
burcu yagmur, Kyrenia University Hospital, Cyprus
Title : Beyond the Heart in Cardiovascular Magnetic Resonance Imaging: Prevalence and Clinical Significance of Incidental Extracardiac Findings
burcu yagmur, Kyrenia University Hospital, Cyprus
Title : Cardiovascular mortality in colon cancer a patient characteristics analysis: Population-based study
Nouf, KAU, Saudi Arabia
Title : Improving Screening and Treatment of Iron Deficiency in Patients with Heart Failure with Reduced Ejection Fraction: A Two-Cycle Quality Improvement Project
Danish Malik, University Hospitals Dorset NHS Foundation Trust, United Kingdom